ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
23/07/2026
Voltar para busca
Dado oficial do USPTO
AVANCE CLINICAL THE CRO FOR BIOTECHS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
AVANCE CLINICAL THE CRO FOR BIOTECHS
ST13
US500000079401298Classe
35, 42
Pedido
79401298
Registro
7988932
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
34
Atualização mais recente
24/07/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
35, 42
Data de depósito
24/05/2024
Data de registro
21/10/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
21/10/2025
Última transação
24/07/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
98
Localização do titular
AU
Examinador
LAVACHE, LINDA M
Unidade examinadora
L60
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
Avance Clinical Pty Ltd
Representantes
David L. May Nixon Peabody LLP
Classificação técnica
Classes Nice
Classe 35Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Business statistical analysis; business statistical studies; compilation of statistics for business purposes; data collection for biotechnology and pharmaceutical companies for business purposes; data compilation for others for business purposes; data management servicesbusiness information management services for use by biotechnology and pharmaceutical companies for business purposes; data management adviceproviding advice in the field of business information management; data management consultancyconsultancy in the field of business information management; data processing servicesdatabase management; data capturecomputer data entry services; data cleansing servicescomputer data entry services in the nature of correcting or removing inaccurate or incomplete data from databases; Data processing servicesupdating and maintenance of data in computer databases; Data processing servicesdata systemization in computer databases; data processing; data processing verification; Data processing servicesdata retrieval; Data processing servicesdata transcriptioncomputer data entry services; demand-based computerised data processing
Classe 42
Advisory services relating to pharmacology; advisory services relating to product testing; advisory services relating to science in the field of pharmacology; advisory services relating to scientific research; development of software systems for the processing of data; development of testing methods in the field of pharmacology; scientific research in the nature of conducting clinical trials for others; scientific research in the nature of conducting clinical trials for others in the field of pharmacology; conducting technical project studiesconducting scientific feasibility studies in the field of pharmacology; consultancy pertaining to pharmacology; medical research; pharmaceutical research services; preparation of reports relating to scientific research; preparation of statistics for scientific researchpreparation of technical reports and analyses of statistical data for scientific research; provision of information relating to scientific research; Product quality testing; research relating to biotechnology; scientific research relating to data processing; research relating to medicine; research relating to pharmaceuticals; scientific and technical analysis in the field of pharmacology; scientific consultancy services relating to pharmacology; scientific testing services in the field of pharmacology; pharmaceutical testing services for assessing the efficiency of pharmaceuticals; pharmaceutical testing services for assessing the safety of pharmaceuticals; technical data analysis services in the field of pharmacology for scientific research purposes; testing of products
Publicações
Histórico de despachos e eventos da marca no USPTO.
34 publicações encontradas
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
28/05/2026
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/05/2026
FIMP
FINAL DISPOSITION PROCESSED
07/05/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
21/01/2026
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
15/01/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
31/12/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
31/12/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
21/10/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
21/10/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/09/2025
PUBO
PUBLISHED FOR OPPOSITION
02/09/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
27/08/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
28/07/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
28/07/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
28/07/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
28/07/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
28/07/2025
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
29/05/2025
GNFR
FINAL REFUSAL E-MAILED
29/05/2025
CNFR
FINAL REFUSAL WRITTEN
29/05/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/05/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/05/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/05/2025
RFNT
REFUSAL PROCESSED BY IB
25/01/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/01/2025
RFRR
REFUSAL PROCESSED BY MPU
04/01/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
17/12/2024
CNRT
NON-FINAL ACTION WRITTEN
16/12/2024
DOCK
ASSIGNED TO EXAMINER
09/12/2024
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
13/09/2024
MAFR
APPLICATION FILING RECEIPT MAILED
06/08/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/08/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/08/2024
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace AVANCE CLINICAL THE CRO FOR BIOTECHS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.